繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
Teladoc Health | 10-Q: Q1 2024 Earnings Report
Teladoc Health | 10-Q: Q1 2024 Earnings Report
Teladoc Health | 10-Q：2024財年一季報
牛牛AI助理已提取核心訊息
Teladoc Health reported a 3% increase in revenue to $646.1 million for the first quarter ended March 31, 2024, compared to $629.2 million in the same period last year. The company's total consolidated Adjusted EBITDA rose to $63.1 million, up from $52.8 million, marking a 20% increase. However, Teladoc Health experienced a net loss of $81.9 million, which is an 18% increase from the previous year's net loss of $69.2 million. The company's Integrated Care segment saw an 8% revenue increase to $377.1 million, with Adjusted EBITDA for the segment growing by 36% to $47.7 million. Conversely, the BetterHelp segment witnessed a 4% decline in revenue to $269 million and a 12% decrease in Adjusted EBITDA to $15.5 million. Teladoc Health's cash and cash equivalents stood at $1.1 billion as of March 31, 2024. The company anticipates recognizing...Show More
Teladoc Health reported a 3% increase in revenue to $646.1 million for the first quarter ended March 31, 2024, compared to $629.2 million in the same period last year. The company's total consolidated Adjusted EBITDA rose to $63.1 million, up from $52.8 million, marking a 20% increase. However, Teladoc Health experienced a net loss of $81.9 million, which is an 18% increase from the previous year's net loss of $69.2 million. The company's Integrated Care segment saw an 8% revenue increase to $377.1 million, with Adjusted EBITDA for the segment growing by 36% to $47.7 million. Conversely, the BetterHelp segment witnessed a 4% decline in revenue to $269 million and a 12% decrease in Adjusted EBITDA to $15.5 million. Teladoc Health's cash and cash equivalents stood at $1.1 billion as of March 31, 2024. The company anticipates recognizing approximately $6.4 million in costs related to the departure of its CEO in the second quarter of 2024. Looking forward, Teladoc Health continues to focus on expanding its whole person virtual care offerings, including primary care, mental health, and chronic condition management, aiming to make virtual care the first step in any healthcare journey.
Teladoc Health報告，2024年3月31日結束的第一季度營業收入爲6461百萬美元，比去年同期的6292百萬美元增加了3%。公司的總合並調整後息稅折舊及攤銷（Adjusted EBITDA）爲631百萬美元，高於去年同期的528百萬美元，增長了20%。然而，Teladoc Health經歷了一項819百萬美元的淨虧損，比去年同期的692百萬美元增加了18%。該公司的綜合護理（Integrated Care）業務段目睹了營收增長8%，達到3771百萬美元，該段的調整後息稅折舊及攤銷增長了36%，達到了477百萬美元。相反，BetterHelp業務段的營收下降了4%，至2690百萬美元...展開全部
Teladoc Health報告，2024年3月31日結束的第一季度營業收入爲6461百萬美元，比去年同期的6292百萬美元增加了3%。公司的總合並調整後息稅折舊及攤銷（Adjusted EBITDA）爲631百萬美元，高於去年同期的528百萬美元，增長了20%。然而，Teladoc Health經歷了一項819百萬美元的淨虧損，比去年同期的692百萬美元增加了18%。該公司的綜合護理（Integrated Care）業務段目睹了營收增長8%，達到3771百萬美元，該段的調整後息稅折舊及攤銷增長了36%，達到了477百萬美元。相反，BetterHelp業務段的營收下降了4%，至2690百萬美元，調整後息稅折舊及攤銷下降了12%，至155百萬美元。截至2024年3月31日，Teladoc Health的現金及現金等價物爲11億美元。該公司預計在2024年第二季度認定約640萬美元與其首席執行官離職有關的成本。展望未來，Teladoc Health繼續致力於擴大其全人虛擬護理服務，包括初級護理、精神健康和慢性病管理，旨在使虛擬護理成爲任何醫療旅程的第一步。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
資訊熱榜
更新時間